InvestorsHub Logo
Followers 13
Posts 4329
Boards Moderated 0
Alias Born 10/27/2020

Re: None

Monday, 11/16/2020 6:18:08 PM

Monday, November 16, 2020 6:18:08 PM

Post# of 18220
For Immune Therapeutics, Inc. (Ticker: IMUN) and it’s shareholders who hold a considerable stake in Cytocom this means the value for all of the years of support and collaboration with Cytocom can be realized. The Cytocom platform technologies and product pipeline, in combination with Cleveland BioLabs, have the potential to drive significant future growth in Immune’s shareholder value.$IMUN